E proteins regulate osteoclast maturation and survival

Journal of Bone and Mineral Research

Volumn 27, Issue 12, 2012, Pages 2476-2489

  Long, Courtney L ^a   Berry, William L ^a   Zhao, Ying ^b   Sun, Xiao Hong ^b   Humphrey, Mary Beth ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CD38; E PROTEINS; OSTEOCLAST; TRANSCRIPTION FACTOR

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD8 ANTIGEN; MEMBRANE RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR E; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MASS; BONE REMODELING; BONE STRUCTURE; CELL COUNT; CELL MATURATION; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; MACROPHAGE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; ANTIGENS, CD38; APOPTOSIS; BONE AND BONES; BONE REMODELING; BONE RESORPTION; CELL DIFFERENTIATION; FEMALE; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; RANK LIGAND; TRANSCRIPTION FACTOR 3;

EID: 84869453877     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1707     Document Type: Article

References (49)

1. Teitelbaum SL, Ross FP., Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003; 4: 638-49.
2. Zhang DE, Hetherington CJ, Chen HM, Tenen DG., The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol. 1994; 14: 373-81.
3. DeKoter RP, Singh H., Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000; 288: 1439-41.
4. Lee ZH, Kim HH., Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun. 2003; 305: 211-4.
5. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA., Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996; 15: 5647-58.
6. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL., Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 1997; 386: 81-4.
7. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R., Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med. 1997 Nov; 3 (11): 1285-9.
8. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U., Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997; 11: 3482-96.
9. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF., Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet. 2000; 24: 184-7.
10. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF., c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994; 266: 443-8.
11. Owens JM, Matsuo K, Nicholson GC, Wagner EF, Chambers TJ., Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines. J Cell Physiol. 1999; 179: 170-8.
12. Bozec A, Bakiri L, Hoebertz A, Eferl R, Schilling AF, Komnenovic V, Scheuch H, Priemel M, Stewart CL, Amling M, Wagner EF., Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. 2008; 454: 221-5.
13. Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, Ostrowski MC, Olsen BR, Glimcher LH., NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J Clin Invest. 2008; 118: 3775-89.
14. Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N., Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett. 2009; 583: 2435-40.
15. Takayanagi H., Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7: 292-304.
16. Nakashima T, Takayanagi H., The dynamic interplay between osteoclasts and the immune system. Arch Biochem Biophys. 2008; 473: 166-71.
17. Kee BL., E and ID proteins branch out. Nat Rev Immunol. 2009; 9: 175-84.
18. Murre C., Helix-loop-helix proteins and lymphocyte development. Nat Immunol. 2005; 6: 1079-86.
19. Ephrussi A, Church GM, Tonegawa S, Gilbert W., B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science. 1985; 227: 134-40.
20. Massari ME, Murre C., Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 2000; 20: 429-40.
21. Jen Y, Weintraub H, Benezra R., Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 1992; 6: 1466-79.
22. Langlands K, Yin X, Anand G, Prochownik EV., Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J Biol Chem. 1997; 272: 19785-93.
23. Cochrane SW, Zhao Y, Welner RS, Sun XH., Balance between Id and E proteins regulates myeloid-versus-lymphoid lineage decisions. Blood. 2009; 113: 1016-26.
24. Tamura M, Noda M., Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J Cell Biol. 1994; 126: 773-82.
25. Funato N, Ohtani K, Ohyama K, Kuroda T, Nakamura M., Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol. 2001; 21: 7416-28.
26. Hayashi M, Nimura K, Kashiwagi K, Harada T, Takaoka K, Kato H, Tamai K, Kaneda Y., Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling. J Cell Sci. 2007; 120: 1350-7.
27. Maeda Y, Tsuji K, Nifuji A, Noda M., Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. J Cell Biochem. 2004; 93: 337-44.
28. Lee J, Kim K, Kim JH, Jin HM, Choi HK, Lee SH, Kook H, Kim KK, Yokota Y, Lee SY, Choi Y, Kim N., Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 2006; 107: 2686-93.
29. Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, Kaplan RN, Rafii S, Rivella S, Lyden D., Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS One. 2009; 4: e7955.
30. Park ST, Sun XH., The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition. J Biol Chem. 1998; 273: 7030-7.
31. Humphrey MB, Daws MR, Spusta SC, Niemi EC, Torchia JA, Lanier LL, Seaman WE, Nakamura MC., TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res. 2006; 21: 237-45.
32. Mõcsai A, Humphrey MB, Van Ziffle JA, Hu Y, Burghardt A, Spusta SC, Majumdar S, Lanier LL, Lowell CA, Nakamura MC., The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci U S A. 2004; 101: 6158-63.
33. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
34. Hsu HL, Wadman I, Baer R., Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc Natl Acad Sci U S A. 1994; 91: 3181-5.
35. Boissy P, Saltel F, Bouniol C, Jurdic P, Machuca-Gayet I., Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin. Endocrinology. 2002; 143: 1913-21.
36. Novack DV, Faccio R., Osteoclast motility: putting the brakes on bone resorption. Ageing Res Rev. 2011 Jan; 10 (1): 54-61.
37. Sun L, Adebanjo OA, Moonga BS, Corisdeo S, Anandatheerthavarada HK, Biswas G, Arakawa T, Hakeda Y, Koval A, Sodam B, Bevis PJ, Moser AJ, Lai FA, Epstein S, Troen BR, Kumegawa M, Zaidi M., CD38/ADP-ribosyl cyclase: a new role in the regulation of osteoclastic bone resorption. J Cell Biol. 1999; 146: 1161-72.
38. Sun L, Iqbal J, Dolgilevich S, Yuen T, Wu XB, Moonga BS, Adebanjo OA, Bevis PJ, Lund F, Huang CL, Blair HC, Abe E, Zaidi M., Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J. 2003; 17: 369-75.
39. Saborit-Villarroya I, Vaisitti T, Rossi D, D'Arena G, Gaidano G, Malavasi F, Deaglio S., E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia. Leukemia. 2011; 25: 479-88.
40. Courtial N, Smink JJ, Kuvardina ON, Leutz A, Gothert JR, Lausen J., Tal1 regulates osteoclast differentiation through suppression of the master regulator of cell fusion DC-STAMP. FASEB J. 2012; 26: 523-32.
41. Kim D, Xu M, Nie L, Peng XC, Jimi E, Voll RE, Nguyen T, Ghosh S, Sun XH., Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities. Immunity. 2002; 16: 9-21.
42. Humphrey MB, Ogasawara K, Yao W, Spusta SC, Daws MR, Lane NE, Lanier LL, Nakamura MC., The signaling adapter protein DAP12 regulates multinucleation during osteoclast development. J Bone Miner Res. 2004; 19: 224-34.
43. Higashida H, Hashii M, Yokoyama S, Hoshi N, Chen XL, Egorova A, Noda M, Zhang JS., Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase. Pharmacol Ther. 2001; 90: 283-96.
44. Malavasi F, Deaglio S, Ferrero E, Funaro A, Sancho J, Ausiello CM, Ortolan E, Vaisitti T, Zubiaur M, Fedele G, Aydin S, Tibaldi EV, Durelli I, Lusso R, Cozno F, Horenstein AL., CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol Med. 2006; 12: 334-41.
45. Zaidi M, Datta HK, Patchell A, Moonga B, MacIntyre I., " Calcium-activated" intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem Biophys Res Commun. 1989; 163: 1461-5.
46. Miyauchi A, Hruska KA, Greenfield EM, Duncan R, Alvarez J, Barattolo R, Colucci S, Zambonin-Zallone A, Teitelbaum SL, Teti A., Osteoclast cytosolic calcium, regulated by voltage-gated calcium channels and extracellular calcium, controls podosome assembly and bone resorption. J Cell Biol. 1990; 111: 2543-52.
47. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T., Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004; 428: 758-63.
48. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T., Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3: 889-901.
49. Iqbal J, Zaidi M., CD38 is required for priming by TNF-alpha: a mechanism for extracellular coordination of cell fate. Am J Physiol Renal Physiol. 2007; 292: F1283-90.